{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-064571","form_type":"8-K","ticker":"DH","cik":"0001861795","company_name":"Definitive Healthcare Corp.","filed_at":"2024-05-24T23:59:59+00:00","discovered_at":"2026-05-14T18:03:20.956212+00:00","generated_at":"2026-06-01T08:52:08.666811+00:00","sec_items":["5.02","5.07","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Appoints Kevin Coop as CEO effective June 24; Founder Krantz remains Executive Chairman","bullets":["Kevin Coop appointed CEO effective June 24, 2024; founder Jason Krantz steps down as interim CEO but stays as Executive Chairman.","Coop receives base salary $500k, target bonus 100%, initial RSU grant of $7.5M value, and performance PSUs with stock price hurdles $10-$27.","At annual meeting, stockholders elected three Class III directors, ratified Deloitte as auditor, and approved say-on-pay on a non-binding basis.","2023 Inducement Plan amended to increase reserved shares to 4.4 million for the inducement grants to Coop."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-064571","json":"https://secwatch.observer/filing/0000950170-24-064571.json","markdown":"https://secwatch.observer/filing/0000950170-24-064571.md","text":"https://secwatch.observer/filing/0000950170-24-064571.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1861795/000095017024064571/0000950170-24-064571-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1861795/000095017024064571/dh-20240520.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T08:52:08.666811+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"5e9ee71590","claim":"Kevin Coop was appointed as Chief Executive Officer at Definitive Healthcare Corp..","evidence_excerpt":"On May 20, 2024, the Board of Directors (the “Board”) of Definitive Healthcare Corp. (the “Company”) appointed Kevin Coop to the position of Chief Executive Officer (“CEO”) and as a member of the Board, each effective June 24, 2024 (the “Start Date”).","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1861795/000095017024064571/0000950170-24-064571-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Executive Officer"}],"fact_type":"executive_change"},{"claim_id":"88dfd807de","claim":"Jason Krantz departed as Interim Chief Executive Officer at Definitive Healthcare Corp..","evidence_excerpt":"Effective on the Start Date, Jason Krantz, the Company’s founder, Executive Chairman of the Board and current Interim CEO will step down from his role as Interim CEO and continue to serve as Executive Chairman of the Board.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1861795/000095017024064571/0000950170-24-064571-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"stepped down"},{"label":"Role","value":"Interim Chief Executive Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}